| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |